危重患儿血糖控制后的长期神经行为与生活质量结局
本研究基于HALF-PINT随机对照试验,纳入32个中心2-16岁有高血糖和心/呼吸衰竭的危重患儿,比较低目标(80-100 mg/dL)与高目标(150-180 mg/dL)血糖控制组1年后的神经行为与健康相关生活质量。结果显示两组Vineland适应行为复合评分无差异,高目标组儿科生活质量总体健康较基线改善更明显。研究不支持低血糖目标带来获益。
要点
- 研究支持低血糖目标对危重患儿长期神经行为结局无额外获益。
核心结论
- 危重患儿低目标与高目标血糖控制1年适应行为无差异,高目标组总体健康较基线改善更明显,不支持低血糖目标获益。
研究设计与样本
- 前瞻性纵向队列研究,比较2种严格血糖控制范围(低目标80-100 mg/dL vs 高目标150-180 mg/dL)1年神经行为与健康相关生活质量结局。
- 研究对象为32个中心入选HALF-PINT随机对照试验的2-16岁有高血糖和心/呼吸衰竭患儿,2012年4月至2016年9月入组,重症监护出院后1年随访。
- 主要结局用Vineland适应行为量表评估适应技能,次要结局用儿科生活质量量表和儿童行为量表评估基线与1年随访。
- 组间差异用回归模型评估,校正年龄类别、基线总体表现和死亡风险。
主要发现
- 369名合格儿童中358名出院存活,214名(60%)完成随访。
临床怎么用
- 对危重患儿采用低目标血糖控制(80-100 mg/dL)未显示长期神经行为获益,临床决策应权衡低血糖风险。
- 高目标血糖控制(150-180 mg/dL)与1年总体健康改善相关,可考虑作为血糖管理策略参考。
局限性
- 仅60%合格患儿完成1年随访,存在失访偏倚可能。
- 研究人群限于有高血糖和心/呼吸衰竭的2-16岁危重患儿,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate adaptive skills, behavior, and quality health-related quality of life in children from 32 centers enrolling in the Heart And Lung Failure-Pediatric INsulin Titration randomized controlled trial. STUDY DESIGN: This prospective longitudinal cohort study compared the effect of 2 tight glycemic control ranges (lower target, 80-100 mg/dL vs higher target, 150-180 mg/dL) 1-year neurobehavioral and health-related quality of life outcomes. Subjects had confirmed hyperglycemia and cardiac and/or respiratory failure. Patients aged 2-16 years old enrolled between April 2012 and September 2016 were studied at 1 year after intensive care discharge. The primary outcome, adaptive skills, was assessed using the Vineland Adaptive Behavior Scale. Behavior and health-related quality of life outcomes were assessed as secondary outcomes using the Pediatric Quality of Life and Child Behavior Checklist at baseline and 1-year follow-up. Group differences were evaluated using regression models adjusting for age category, baseline overall performance, and risk of mortality. RESULTS: Of 369 eligible children, 358 survived after hospital discharge and 214 (60%) completed follow-up. One-year Vineland Adaptive Behavior Scale-II composite scores were not different (mean ± SD, 79.9 ± 25.5 vs 79.4 ± 26.9, lower vs higher target; P = .20). Improvement in Pediatric Quality of Life total health from baseline was greater in the higher target group (adjusted mean difference, 8.2; 95% CI, 1.1-15.3; P = .02). CONCLUSIONS: One-year adaptive behavior in critically ill children with lower vs higher target glycemic control did not differ. The higher target group demonstrated improvement from baseline in overall health. This study affirms the lack of benefit of lower glucose targeting. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01565941.
引用
- Biagas KV, Hinton VJ, Hasbani NR, et al. Long-Term Neurobehavioral and Quality of Life Outcomes of Critically Ill Children after Glycemic Control. J Pediatr. 2020. PMID: 31910992. doi:10.1016/j.jpeds.2019.10.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。